Provectus Biopharmaceuticals (PVCT) Total Debt (2017 - 2026)
Provectus Biopharmaceuticals' Total Debt came in at $92,443 for Q2 2026, up 70.1% from $54,337 a year earlier.
Powered by 
Analysis
Provectus Biopharmaceuticals (PVCT) Total Debt (2017 - 2026) Analysis & Trends
At the end of FY2025, Provectus Biopharmaceuticals' Total Debt was $241,393, up 16.9% from FY2024.
- Total Debt carries a five-year compound annual growth rate of -57.1% (FY2020 to FY2025).
- Going back by year, Total Debt was $206,463 in FY2024 (-25.7%), $277,815 in FY2023 (-55.5%), $625,000 in FY2022 (-50.4%) and $1.26 million in FY2021 (-92.4%).
- The five-year range for quarterly Total Debt is $54,337 (Q2 2025) to $1.81 million (Q3 2022).
- Year-over-year, Total Debt increased in three of the last seven quarters, with an average decline of 13.2%.
- The fastest year-over-year change in Total Debt over five years came in Q3 2022 (growth of 805.0%), and the weakest in Q3 2021 (a decline of 98.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 44.65 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 63.19 Bn |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 92,443.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 92,443.00 |
| Dec 31, 2025 | 459,165.00 |
| Sep 30, 2025 | 258,962.00 |
| Jun 30, 2025 | 54,337.00 |
| Mar 31, 2025 | 124,578.00 |
| Dec 31, 2024 | 206,463.00 |
| Sep 30, 2024 | 110,544.00 |
| Jun 30, 2024 | 109,862.00 |
| Mar 31, 2024 | 190,910.00 |
| Dec 31, 2023 | 277,815.00 |
| Sep 30, 2023 | 853,066.00 |
| Jun 30, 2023 | 148,273.00 |
| Mar 31, 2023 | 730,097.00 |
| Dec 31, 2022 | 864,394.00 |
| Sep 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 1.46 Mn |
| Dec 31, 2021 | 1.50 Mn |
| Sep 30, 2021 | 268,392.00 |
| Jun 30, 2021 | 127,393.00 |
API Access
Provectus Biopharmaceuticals Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=PVCT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();